BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,225,908 | +25.1% | 32,483 | +51.0% | 0.02% | +20.0% |
| Q2 2023 | $980,132 | +13.5% | 21,513 | +1.1% | 0.02% | +7.1% |
| Q1 2023 | $863,482 | -55.3% | 21,289 | -43.8% | 0.01% | -54.8% |
| Q4 2022 | $1,930,438 | +4.7% | 37,874 | +10.7% | 0.03% | -11.4% |
| Q3 2022 | $1,843,000 | -35.2% | 34,220 | -22.8% | 0.04% | -34.0% |
| Q2 2022 | $2,846,000 | +9.0% | 44,310 | +31.6% | 0.05% | +23.3% |
| Q1 2022 | $2,611,000 | +168.1% | 33,678 | +196.8% | 0.04% | +152.9% |
| Q4 2021 | $974,000 | +92.5% | 11,346 | +80.4% | 0.02% | +70.0% |
| Q3 2021 | $506,000 | +84.0% | 6,290 | +84.1% | 0.01% | +100.0% |
| Q2 2021 | $275,000 | +36.1% | 3,416 | +42.8% | 0.01% | +25.0% |
| Q1 2021 | $202,000 | +5.8% | 2,392 | +0.3% | 0.00% | -20.0% |
| Q4 2020 | $191,000 | -9.0% | 2,384 | -8.8% | 0.01% | -16.7% |
| Q3 2020 | $210,000 | +14.8% | 2,613 | +23.0% | 0.01% | 0.0% |
| Q2 2020 | $183,000 | +553.6% | 2,124 | +513.9% | 0.01% | +500.0% |
| Q1 2020 | $28,000 | -64.1% | 346 | -62.7% | 0.00% | -50.0% |
| Q4 2019 | $78,000 | -92.6% | 927 | -92.3% | 0.00% | -92.0% |
| Q3 2019 | $1,053,000 | – | 12,033 | +1203200.0% | 0.02% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $3,043,000 | +3.4% | 41,245 | -8.9% | 0.06% | 0.0% |
| Q1 2018 | $2,944,000 | -15.2% | 45,268 | -15.7% | 0.06% | -21.0% |
| Q4 2017 | $3,472,000 | -39.9% | 53,715 | -41.7% | 0.08% | -39.6% |
| Q3 2017 | $5,779,000 | +1.9% | 92,091 | -1.7% | 0.13% | +0.8% |
| Q2 2017 | $5,669,000 | +20.6% | 93,643 | +3.3% | 0.13% | +19.8% |
| Q1 2017 | $4,700,000 | +30.7% | 90,636 | +11.7% | 0.11% | +30.6% |
| Q4 2016 | $3,597,000 | -0.9% | 81,126 | +6.4% | 0.08% | 0.0% |
| Q3 2016 | $3,629,000 | +55.6% | 76,234 | +47.8% | 0.08% | +41.7% |
| Q2 2016 | $2,332,000 | +46540.0% | 51,566 | +68654.7% | 0.06% | – |
| Q2 2015 | $5,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |